[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
May 2010

Mitochondrial Neurogastrointestinal Encephalopathy Without Elevated Thymidine Levels

Author Affiliations

Author Affiliations: Department of Neurology, Kings College Hospital, London, and Department of Neurology, Kent and Canterbury Hospital, Canturbury (Dr Moran); and the Departments of Child Health (Dr Baine), and Clinical Developmental Sciences (Dr Bax), St George's University of London, London, England.

Arch Neurol. 2010;67(5):644-645. doi:10.1001/archneurol.2010.73

Shaibani et al1 describe a patient with the phenotype of mitochondrial neurogastrointestinal encephalopathy (MNGIE) with a plasma thymidine concentration within the reference range. However, we believe their assertion that the reference plasma thymidine concentration is less than 150 mmol/L is incorrect; the accepted reference concentration is nearer to less than 0.05 μmol/L. The thymidine concentration of 100 mmol/L in the patient described, therefore, is markedly elevated. This is important because a high concentration of thymidine is thought to be central to the pathogenesis of MNGIE and, consequently, the aim of endeavors to treat MNGIE (principally bone marrow transplant and enzyme replacement) has been to achieve sustained lowering of plasma thymidine.24 The occurrence of MNGIE in the absence of elevated thymidine would represent an important challenge to the validity of this approach; therefore, we would welcome clarification by Shaibani et al.

First Page Preview View Large
First page PDF preview
First page PDF preview
×